Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 10/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.61 |
| ▸ | TP53 | P04637 | 7/20 | 0.61 |
| ▸ | RAB9A | P51151 | 6/20 | 0.61 |
| ▸ | MEN1 | O00255 | 5/20 | 0.61 |
| ▸ | NPC1 | O15118 | 5/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.61 |
| ▸ | HPGD | P15428 | 3/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.61 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.61 |
| ▸ | RELA | Q04206 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 3/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29859543 | 1.00 | MAPT (0.61) | MAPTSMN1; SMN2TP53RAB9AMEN1 | |
| SCHEMBL23630626 | 0.93 | RAB9A (0.54) | MAPTSMN1; SMN2TP53RAB9AMEN1 | |
| SCHEMBL29859412 | 0.93 | RAB9A (0.54) | MAPTSMN1; SMN2TP53RAB9AMEN1 | |
| SCHEMBL23630624 | 0.89 | MAPT (0.54) | MAPTSMN1; SMN2TP53RAB9AMEN1 | |
| SCHEMBL29859231 | 0.89 | MAPT (0.54) | MAPTSMN1; SMN2TP53RAB9AMEN1 | |
| SCHEMBL12304282 | 0.88 | RAB9A (0.47) | MAPTSMN1; SMN2TP53RAB9AMEN1 | |
| SCHEMBL23642857 | 0.86 | MAPT (0.48) | MAPTSMN1; SMN2TP53RAB9AMEN1 | |
| SCHEMBL30129872 | 0.85 | RAB9A (0.46) | MAPTSMN1; SMN2TP53RAB9AMEN1 | |
| SCHEMBL13866097 | 0.85 | RAB9A (0.46) | MAPTSMN1; SMN2TP53RAB9AMEN1 | |
| SCHEMBL28823008 | 0.82 | MAPT (0.64) | MAPTSMN1; SMN2TP53RAB9AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4437027-A1 | DUAL UV BLOCKERS CONTAINING STABLE PHOTOACTIVE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS OPTICAL MATERIALS | Promerus, LLC (US) | 2024-10-02 | — | — | EP | claimed |
| EP-4087889-B1 | STABLE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS 3D PRINTING MATERIALS AND A METHOD OF FABRICATION THEREOF | PROMERUS LLC (US) | 2024-03-06 | — | — | EP | claimed |
| WO-2023097092-A1 | DUAL UV BLOCKERS CONTAINING STABLE PHOTOACTIVE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS OPTICAL MATERIALS | PROMERUS, LLC (US) | 2023-06-01 | — | — | WO | claimed |
| EP-4087889-A1 | STABLE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS 3D PRINTING MATERIALS AND A METHOD OF FABRICATION THEREOF | Promerus, LLC (US) | 2022-11-16 | — | — | EP | claimed |
| WO-2021142402-A1 | STABLE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS 3D PRINTING MATERIALS AND A METHOD OF FABRICATION THEREOF | PROMERUS, LLC (US) | 2021-07-15 | — | — | WO | claimed |
| EP-4744462-A1 | COMPOSITION | Merck Patent GmbH (DE) | 2026-05-20 | — | — | EP | disclosed |
| WO-2025012183-A1 | COMPOSITION | MERCK PATENT GMBH (DE) | 2025-01-16 | — | — | WO | disclosed |
| EP-4437027-A1 | DUAL UV BLOCKERS CONTAINING STABLE PHOTOACTIVE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS OPTICAL MATERIALS | Promerus, LLC (US) | 2024-10-02 | — | — | EP | disclosed |
| US-12037431-B2 | Stable mass polymerizable polycycloolefin compositions as 3D printing materials and a method of fabrication thereof | PROMERUS, LLC (US) | 2024-07-16 | — | — | US | disclosed |
| US-12037431-B2 | Stable mass polymerizable polycycloolefin compositions as 3D printing materials and a method of fabrication thereof | PROMERUS, LLC (US) | 2024-07-16 | — | — | US | disclosed |
| WO-2024083874-A1 | COMPOSITION | MERCK PATENT GMBH (DE) | 2024-04-25 | — | — | WO | disclosed |
| EP-4087889-B1 | STABLE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS 3D PRINTING MATERIALS AND A METHOD OF FABRICATION THEREOF | PROMERUS LLC (US) | 2024-03-06 | — | — | EP | disclosed |
| US-20230167256-A1 | DUAL UV BLOCKERS CONTAINING STABLE PHOTOACTIVE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS OPTICAL MATERIALS | PROMERUS, LLC (US) | 2023-06-01 | — | — | US | disclosed |
| US-20230167256-A1 | DUAL UV BLOCKERS CONTAINING STABLE PHOTOACTIVE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS OPTICAL MATERIALS | PROMERUS, LLC (US) | 2023-06-01 | — | — | US | disclosed |
| US-11535702-B2 | Long shelf life stable photoactive mass polymerizable polycycloolefin compositions as optical materials | PROMERUS, LLC (US) | 2022-12-27 | — | — | US | disclosed |
| EP-4087889-A1 | STABLE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS 3D PRINTING MATERIALS AND A METHOD OF FABRICATION THEREOF | Promerus, LLC (US) | 2022-11-16 | — | — | EP | disclosed |
| WO-2022169801-A1 | LONG SHELF LIFE STABLE PHOTOACTIVE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS OPTICAL MATERIALS | PROMERUS, LLC (US) | 2022-08-11 | — | — | WO | disclosed |
| US-20220235161-A1 | STABLE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS 3D PRINTING MATERIALS AND A METHOD OF FABRICATION THEREOF | PROMERUS, LLC (US) | 2022-07-28 | — | — | US | disclosed |
| US-20210221931-A1 | STABLE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS 3D PRINTING MATERIALS AND A METHOD OF FABRICATION THEREOF | PROMERUS, LLC (US) | 2021-07-22 | — | — | US | disclosed |
| WO-2021142402-A1 | STABLE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS 3D PRINTING MATERIALS AND A METHOD OF FABRICATION THEREOF | PROMERUS, LLC (US) | 2021-07-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12037431-B2 | Stable mass polymerizable polycycloolefin compositions as 3D printing materials and a method of fabrication thereof | RRP15, PPOX, NONO | MAPT 55/4885SMN1; SMN2 4228/4885TP53 2803/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.